N
Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:michael olise500+bank of america fine1000+club brugge200+rb leipzig200+anthony gordon500+mid atlantic ridge earthquakes500+montez sweat2000+rob lowe1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Lilly outpaces Novo as US" (30 stories)

Top Headline Story

Eli Lilly's Obesity Treatments Outpace Novo Nordisk
Lead Story조선일보general
Aug 19

Eli Lilly's Obesity Treatments Outpace Novo Nordisk

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOcFN3MTRkT19BVnJTUjVpR0M4Y0xMSGZzZkdwWVYxSkRSN0twdjNtTXpSZl8wVVJyZzg5VlpxMXp0NzFXWXFHZ21kN1VqbEF3NWxLbnI0dnROUEtNbmlQZzduRnNCRUloZ1BTZzJXWGhHV1V3d20yWF9tRUtuR25aQlN4aGFjN095?oc=5" target="_blank">Eli Lilly's Obesity Treatments Outpace Novo Nordisk</a>  <font color="#6f6f6f">조선일보</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
500+14m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

Filter stories
1000+14m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

Filter stories
200+14m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

Filter stories
200+14m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Filter stories

Search Results for "Lilly outpaces Novo as US"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
The Motley Foolgeneral

Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNc3dvdExTQkRFODUya2c5WFdXMVVVNEItcEZXdVI3cndoVVBKQi1XX25DYzEyejdGQ2k4ZU45OVFvWnFMcnZBUER0N3lWVjRpREtIRl9PTmJEYTgyTkpXUi1pdlVhTUtDdFVSNEhTUHFWbi1UV2h4ZDh4YU4wM1F5RzlIUTU5YVV5bHVPVDZOdmJ6LUFOMHY0OA?oc=5" target="_blank">Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst</a>  <font color="#6f6f6f">The Motley Fool</font>

Read Full StoryMore like this
Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)
Seeking Alphageneral

Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQanBfYWRoWU44LUtnOVNZLWpRRk5QaVIxa1JtTy10YnY5di1SRGpoclc3SVpjT2pPLXJkQnNjZ0hEZ2F1VWo2NE1QSFJvMG50ekFKLUNTSkNfZ3kta2hGV01MQ3pvRWM5NTZiQkVvcEJhY1Ntd3VCTzR3OHNyc3Y0Qmo4U2FKY1lXQ2xtQmNsNTkyZDdWR05tMEhIMk9uNnExcHVpbg?oc=5" target="_blank">Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk (NYSE:LLY)</a>  <font color="#6f6f6f">Seeking Alpha</font>

Read Full StoryMore like this
Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush
24/7 Wall St.general

Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQWEtLWndZSU5qcTQ2bXA5aUF1RXp0QWZXMHdEMDEyMDU1YXQydjZRbTNCRlB6TlF1LXMwZ1RlUTQzWlFqYkdyUWtyRkNsY2Uza2d6TjgtSmhnLW1PcmYxRlE5Vk5GRXdqZWt0SjZLS2FfQU5JWndRU1FjUTdneFV4YVlnUVVPUGhVUUZPX3ZtZGFwMExHbjhiX3AxRnN4T3hBVTRkQ0U4Smh2VFB2eE1GZXJqZzY?oc=5" target="_blank">Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush</a>  <font color="#6f6f6f">24/7 Wall St.</font>

Read Full StoryMore like this
Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance
CNBCgeneral

Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOQWI1Q2FCMmFob3FzS3g5Z3o1SG1yV1YzaEpJQTFFUU52SWU3NGVlLXRkbUZPUGtKenBMM1lRUFR1b1E5QVd5MVRxd19mRUNKMXNyOEhNclJKTDcxbG9vRkttVmkwWUE4ampKLU0yNWRnMFltNzYtM0gxN0ZKQTJDUUZVMzlWMndGcWZLOGVVTkplRWRfRlZITEN30gGfAUFVX3lxTE9ZWGtBcmo0T2VGdkxyeG9NczBQSTkwTDJjdVRhZXVrY0NsY1hyUEhBb1M3M0xmQ2dRVTI4VjdWRWU3Qm5JSFRtWFROSWNpY1FtaGZYTkNPR0dTUC0yd1pTUXhIQnZmUWw3bzdIazVEVDNPNl9kNzRCOWtFSC1zX1VITndCT0F5QndjNTg0Q3JIQm5nbm1JaXdMZzl6a3ozMA?oc=5" target="_blank">Novo Nordisk’s head start on GLP-1 pills forces investors to rethink Eli Lilly's dominance</a>  <font color="#6f6f6f">CNBC</font>

Read Full StoryMore like this
Eli Lilly Climbs to No. 3 in Pharma as Mounjaro Outpaces Wegovy Momentum
thelec.networld

Eli Lilly Climbs to No. 3 in Pharma as Mounjaro Outpaces Wegovy Momentum

<a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE16anRQeHBRUjBSX1VtaTJHcjhoNGRfMlBVdmd2ZzBQSjk2dTJWcnd5Qk5qNnN1WW9vMjBlT3RLZ095bGZiaVZOUWJBR2M0aXllTDNZMkVWVDZVUUdDSy0yMmQ2MFk4QQ?oc=5" target="_blank">Eli Lilly Climbs to No. 3 in Pharma as Mounjaro Outpaces Wegovy Momentum</a>  <font color="#6f6f6f">thelec.net</font>

Read Full StoryMore like this
Despite Novo Nordisk's flying start with Wegovy pill: Eli Lilly EVP confident in maintaining lead
medwatch.comtech

Despite Novo Nordisk's flying start with Wegovy pill: Eli Lilly EVP confident in maintaining lead

<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1VTHNkdDdHRGdKTWVRekpkV21TZ3dfMnBSUmFrMzRxNUs5LURVRy1WbEhFa2J6azA3TE9sMWl3ZlgzSGJZNTFLWVB0eFdYdDdCdHg0X0hsak1CcUpyclp2ZVBvZ2JiV3Y2d0tyRC1qdw?oc=5" target="_blank">Despite Novo Nordisk's flying start with Wegovy pill: Eli Lilly EVP confident in maintaining lead</a>  <font color="#6f6f6f">medwatch.com</font>

Read Full StoryMore like this
Novo Nordisk Momentum: Oral Wegovy Keeps Edge Over Lilly's Foundayo in Obesity Drug Race - News and Statistics
IndexBoxworld

Novo Nordisk Momentum: Oral Wegovy Keeps Edge Over Lilly's Foundayo in Obesity Drug Race - News and Statistics

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNdkVqSXowNldoUURpekIwd0JDNldXVzhRaFJzaFVLamxQN21IdjVJNmoxRzQ3TG9CYzc3TzFtUFNuY1docl9jaWQ2T2JnMHhzV3JlTTdKUElJemRjU2ZaTWg0RHdvakdETV9GNTNlTFMwNUlhc2k2dUl0TnFFTnMxWTA1TGxjOWJEd0MzYXo5QjhQN21CRFdQX3pqa25Bejd4c0huODVoVlNpWWRw?oc=5" target="_blank">Novo Nordisk Momentum: Oral Wegovy Keeps Edge Over Lilly's Foundayo in Obesity Drug Race - News and Statistics</a>  <font color="#6f6f6f">IndexBox</font>

Read Full StoryMore like this
Lilly’s Mounjaro, Zepbound Sales Soar, Outpacing Novo Nordisk Rival
Global Banking & Finance Reviewworld

Lilly’s Mounjaro, Zepbound Sales Soar, Outpacing Novo Nordisk Rival

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxONFdvWkdoNVRoQlB6SW41RTRjU25mZXJ6QUE0bF95c281UWRxb3o4MVlIdGp2UkV1R3Rad014TFpNZjU0a19fYVpBanN4eFRqZTBtUGhlZHFTZXd1em9hMHB2X0tjUkxqN3lrclRjMVVTYXVOZ2VGelFzdUdaYlpXZ09uV202MkpieXdPbFl3WkVRZ2NZVk1JQVpqc0NsUUxPRmg0?oc=5" target="_blank">Lilly’s Mounjaro, Zepbound Sales Soar, Outpacing Novo Nordisk Rival</a>  <font color="#6f6f6f">Global Banking & Finance Review</font>

Read Full StoryMore like this
Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up
Yahoo Finance UKgeneral

Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxOZ2ZLcDh2YlFxZXlkempFLWsyOS1rRTI2TDdxdk83M1RtanBmZVNzeDVkVTBwai12ZTdBRzQwbHZ3QWdDVGFEbndWbTcwU1VzV3haOUZMdkR4dXBlbUFXMndmQ2NJTV9NSlJnMGNqazQteTgwbGhjZzdCbXVFZWhaWWs3RDZub0E?oc=5" target="_blank">Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up</a>  <font color="#6f6f6f">Yahoo Finance UK</font>

Read Full StoryMore like this
Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
The New York Timesgeneral

Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNVi1iU2J2UUF0NUoyQ3VPWHJZQUpFeTdtMFl4UXdEdTJaOENFa2IxVGpzUzVzQ2p4MnN3WnZZTjJlZ29yMmZMcVBmMjJVRVZoOWV4Ykd1N0JxeHBZSFIydk4wNVJ6bnRHc1o1QS1NTERDaHZuR2hjTnVZWjhLWFRScG1xd28yWlg3WUVv?oc=5" target="_blank">Novo Nordisk Warns of First Sales Drop Since Start of Ozempic</a>  <font color="#6f6f6f">The New York Times</font>

Read Full StoryMore like this
LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?
TradingViewmarkets

LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNExRNUpFLUpJLWNOZ0lBc1Q2NWp1WmFja2pyU3Y3THZ1aGZKX09ZV1NIQnRKbmNxQlB3QVVNQlhPUWhEdy1HelBvQzl4WjM1WWxad1NWbWFJNHRGYlR0WVY2cm9PQTJhZFVkMWhXN2E5OUFyMndLd0cza0JSTVhKck9WQWVqUEtHOHlhYlQyb2JGYUdLZXM5TFl1dGpyMUtveklFRkgtaTJUZ3oteDQ2TFlic19hY041Rm9faDB6YW44dw?oc=5" target="_blank">LLY Stock Up on GLP-1 Pill Approval: Can it Outpace NVO's Wegovy Pill?</a>  <font color="#6f6f6f">TradingView</font>

Read Full StoryMore like this
Eli Lilly becomes first drugmaker to reach $1 trillion valuation on weight-loss boom
Ynetnewsgeneral

Eli Lilly becomes first drugmaker to reach $1 trillion valuation on weight-loss boom

<a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFB6RWZ6S1NEV3BjVDY1aWdUTFc1bEJxZmVCdGthMzBFVEV4XzZDTU9KbmVYaDl4cmIyeFNkclZSUHR5LXF1R1RBTWo0TlNPUmtqQVJoVkY0NnhsbzRaTFNKS2VB?oc=5" target="_blank">Eli Lilly becomes first drugmaker to reach $1 trillion valuation on weight-loss boom</a>  <font color="#6f6f6f">Ynetnews</font>

Read Full StoryMore like this
Lilly outpaces Novo as US price cuts split obesity drug fortunes - CHOSUNBIZ
Chosunbizworld

Lilly outpaces Novo as US price cuts split obesity drug fortunes - CHOSUNBIZ

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQcndXRG8yUGxoUElNS1p3bUJFRVItTEN6TTFyNFRZRUZKMWNUNWNuN091MjFXTHZwWUttd3d2Q3JSc1hQcnFFQ3pxQXpzQl9TOWp6b3lGTm9rcnRDazdmSmpZMy1kLUE5U283RUpaRHVRQ0xjQnFKNFVuZ19OclB3WNIBlAFBVV95cUxQdDRqVVV1MlZ4T18zamdfRFJWSTBsMTRJY3ItSjNMdV9oc2xlNW9kY1UtTWVBY0lLQXl4WW44bWNUeERFRDlMXzh4TTJrd3BTb3REeVFUeDU1WHVkb1Q1alJYMHZYRmhjNWxSekNBWHpoZzhrc1BncENZSHZHRzBOSzVaZVNLOE1uNmpyYmxXODdhNFdV?oc=5" target="_blank">Lilly outpaces Novo as US price cuts split obesity drug fortunes - CHOSUNBIZ</a>  <font color="#6f6f6f">Chosunbiz</font>

Read Full StoryMore like this
Eli Lilly Earnings: International Tirzepatide Sales Outpaced Our Expectations
Morningstargeneral

Eli Lilly Earnings: International Tirzepatide Sales Outpaced Our Expectations

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQcHo0LVpzSjRsRE5hUlhYQXVvaWlPd3NCdTFwQ2lSaTBkT19fMFAwR0JDNFFPb3p0UF9fNDZYcFQ1OFczdXFreHctNzFtcFVxTmFnMHhHM25FNGdpaUJSbjVMVThPN3lmd2tYbVVOSnVPMWk5V19CSVRpbndqanFlaTM4cDZLVzI2YXl1ODhOQzZ4clBGdkRMa2JQN2pfMnFJWWdYSVZ6d1gtdGhYWGJiSg?oc=5" target="_blank">Eli Lilly Earnings: International Tirzepatide Sales Outpaced Our Expectations</a>  <font color="#6f6f6f">Morningstar</font>

Read Full StoryMore like this
Eli Lilly Trumps Novo Nordisk In GLP-1 Race - Multi-Year Growth Prospects (NYSE:LLY)
Seeking Alphageneral

Eli Lilly Trumps Novo Nordisk In GLP-1 Race - Multi-Year Growth Prospects (NYSE:LLY)

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQYVZaM053WmxuSmU2cUdFWkh4RVE5M2l0RU9vQk1Bb0k0ZVdFWVB6UzNFN1hid0NjamhzQWd1cXZERUNvVDU5anJZOVVqMjdtMTM0ajlVS0xQVG9hMGZDeDFVLVpGNlllNEk0eGZmOE1iTGUyMkpUV3B3ODhhQnQ0NVRrQmpnN1lnYTJpTzVWTFRSZEI5dHhDZjhpbExtdnRNazFhUFBYeHBvRFpscjVQdGh3?oc=5" target="_blank">Eli Lilly Trumps Novo Nordisk In GLP-1 Race - Multi-Year Growth Prospects (NYSE:LLY)</a>  <font color="#6f6f6f">Seeking Alpha</font>

Read Full StoryMore like this
Novo Nordisk unlocks new patient poll for semaglutide pill with positive Phase 3 readouts
ETPharma.comworld

Novo Nordisk unlocks new patient poll for semaglutide pill with positive Phase 3 readouts

<a href="https://news.google.com/rss/articles/CBMi_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?oc=5" target="_blank">Novo Nordisk unlocks new patient poll for semaglutide pill with positive Phase 3 readouts</a>  <font color="#6f6f6f">ETPharma.com</font>

Read Full StoryMore like this
Eli Lilly beat Wall Street expectations, raising full-year sales to $85b
Morning Brewtech

Eli Lilly beat Wall Street expectations, raising full-year sales to $85b

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxPMElKNUtNM09QMXVQTUpSZmVhNkNWVHBobzZfUFJqREZWbm5BUkNYa1F1WGlhQldHY3VLZjlqUjd2NERoMVNIX1FOMzdkVFNieWo2S2FfeFBGd2N2bFh5QU1QLTljSEhNSGllajJyVzVVZTV5T2JaRzVwR0RCb3dDdjNCV08yLWJDakE?oc=5" target="_blank">Eli Lilly beat Wall Street expectations, raising full-year sales to $85b</a>  <font color="#6f6f6f">Morning Brew</font>

Read Full StoryMore like this
Wegovy Pill Outpaces Foundayo in Early U.S. Prescriptions
조선일보world

Wegovy Pill Outpaces Foundayo in Early U.S. Prescriptions

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxQclVnMXBmQlNLV0hGbFJNdVhNcVZiLU52dy1obWFlZGhiS2YxbEkyZktEclBrSUl3VEVWaWlMSVRaNmk0amJ3NzRmSV9NRFB2ZG9UUlZDdnEwc09sVVdYcXRCdHlSVFlkekdYVWlPUTk5U3o4ZzdOSDdhUVplQnV3TlhMMndVWUE1?oc=5" target="_blank">Wegovy Pill Outpaces Foundayo in Early U.S. Prescriptions</a>  <font color="#6f6f6f">조선일보</font>

Read Full StoryMore like this
Novo boosts rebound hopes as oral Wegovy drives Q1 sales surge - CHOSUNBIZ
Chosunbizworld

Novo boosts rebound hopes as oral Wegovy drives Q1 sales surge - CHOSUNBIZ

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQNDhBQWJtbWVLbWQ4X2RDNXR2dmVSdmdqVGF4S25PSDlOb1J1UGV6YjhYYWFYSlZNbXgxZkpLc0M5SndBZ3FLRVRMV0Y0M1Zva0d3RzRTdHNEbnZBLVJ5TE5xWVZCdmw0MHNfYUxwOHA3TFFTd08tcnNkTnZuZFRCS9IBlAFBVV95cUxOczhpSDBXazgxMTN1a1RPZTlRd3N3cjlOWmpxc1pmeVpWUFZWYmN5SzZvQVpFQjRCQjNFdlJQRlZCVXl2dV84dzBkM3FsSjctc1BoWUFJaTEwWmdSVFB0REhzdDJkNDQtaF9wVnlIdWkydWgxSmpPRmN3OFpLUG0wSlBZVWZwX3hKamp5NnpGdEdPQWg1?oc=5" target="_blank">Novo boosts rebound hopes as oral Wegovy drives Q1 sales surge - CHOSUNBIZ</a>  <font color="#6f6f6f">Chosunbiz</font>

Read Full StoryMore like this
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study
Reutersworld

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxOV2FUY2RMMFhZbG1TbklKV0ZGUnRMU3VvRTk2RHExTEV6QVlnSVdMT2h6bFhoN3NDT1VFekJjUmVVUUJVMTViNDdwcWlMdXIxZ0hiZ0tDeFo1Z1dwVHlkWkhBY3ppRGVXeHhXTDFGdVNjZnZyYW0tcVg5NGdITmJDTXVhNy0yLURsM2JuRlhqaURZUUFKd2JHNnZ5ZkIycEE5YndnSFdoYXBVNUhhbVlHVE11dFZyM0tidVU1dmloZ2lDaGtrbThN?oc=5" target="_blank">Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Novo Nordisk rebrands as 'Novo', announces cultural reset
Reutersworld

Novo Nordisk rebrands as 'Novo', announces cultural reset

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxOYno4bUZsWF9aVmRQSVZDTXVsOXh6S2RFVHZiZEplNmlIY2lTekRNaW10Q25EOWFjLUVvNFRTMm1Ua2VsVHdsa2x1anZzcWhLTUZ0Z24zSFdNb2k2b2NvUWdGNzlLc2lqdVJXaWl6Tm1CX0ZHYnZ0ZWJFQmlwMUV6LW5zaWk3SlBRdkJvUVFIU2xySk5YamdZREJpaXl0UkQxNU9UYzFJU3FCQ1k?oc=5" target="_blank">Novo Nordisk rebrands as 'Novo', announces cultural reset</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand
Reutersgeneral

Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQR2IxVV9iQW1qWVBVaWZIZW5hdDJZM2liR3FpeXNaRzM3Ukdia3BiVEd5R1R3RWVydEwyeDh6V3FsXzM5TDh5T3pfYWZzNzljb0Nrc3VlNUZST1M4YUpsaEw4OXVQaldZbWVVbm1QZzlsd2JIMWNqamczX3FMOVNhWVNWcWRSekIwYWVUM29YQ0xJNTZoTmtLSk5BUnBJYUNncEx0RzlpeFg5Ym5TV3ZlWmpPRG1IZzJZclptRmpESndXZHdZbGFrcjNYdmVZM1UyMTFQNHJUakMxVUE4a05GX05XODBzdw?oc=5" target="_blank">Lilly becomes first drugmaker to hit $1 trillion valuation on weight-loss demand</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Heavy weights: North Carolina is at the heart of a great American obesity drug race
Raleigh News & Observergeneral

Heavy weights: North Carolina is at the heart of a great American obesity drug race

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE84VDM2bzZxZXI1REJ6TW5PZHQ2anVkRjBFTjF4NGJ0YVlLeDRqaXNHUmd1cmowYjNHcmswTF9fQmNhTlJIZmx2YVhWQk15QVFTVndMb09DRU9xZU1BM1ZwNjEtb3ByOE9Vc3FzUzBabTAzQdIBckFVX3lxTE1VS0dUMjdDTEZQMVlWd0FuTkZMSlBpTjNjSXNuVUhLOU05VTdSTV9XX3pLRXJlcFJFRkdpdG95WmJzMzlMRTEzOXdqSGJBc0dDa2JGQjFoV3NtcEJrRGZUakozbzJyb1lEbXFaaXJtcW1Fdw?oc=5" target="_blank">Heavy weights: North Carolina is at the heart of a great American obesity drug race</a>  <font color="#6f6f6f">Raleigh News & Observer</font>

Read Full StoryMore like this
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs
WHBL Newsgeneral

Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNdFM1RndMY1V5dDFKdGItWXlySXN6QnRzQVYzR1hWQ3NzX2V6ZDN0aTlWWlFTaWMwMkhQVVk2UG1wMDUxNFpIcFBDLU5PVWlRdDVSV3JhNjJIMzRpdWw2RmZIc3E0aUtZNDM0ZUs2azc5MjRkWmh6TDd2ZVQtVlE0ZXVxRW1OUUpmVjVsM2trdDF2N3NCTWNtVzBPQzJnT0lsZG1VYVFn?oc=5" target="_blank">Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs</a>  <font color="#6f6f6f">WHBL News</font>

Read Full StoryMore like this
What Novo Nordisk's weight-loss pill approval means for company, patients
Reutersgeneral

What Novo Nordisk's weight-loss pill approval means for company, patients

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxOcFVBUjVuZHhYY1V6Ul9CbFdqcDBQUk5aZlc3QTNxVFVacW1oMWVFaEczaUNFN2xfZWp2MjRmV0M5V2FaRG1WU0xUc183Ql9zcWc5eDBaYUlISmJZSjBXa1pRc1V0dWtKY1dUMUVVZTdBd1pUQjZkR1puUHhKdEJkbUdsOXVnRldTbC00NENyQVh1LUVzRXBqOHlaeHpvUlF0QTBlQ19HOVg5NDNaSS1HR1ZDcHB4dkhEYVhBbG9sQkRWanFxSkNCd2NLRHFkSDFVclpOMEN3?oc=5" target="_blank">What Novo Nordisk's weight-loss pill approval means for company, patients</a>  <font color="#6f6f6f">Reuters</font>

Read Full StoryMore like this
Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried?
The Motley Foolmarkets

Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried?

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNTnk3WDlqMjE5T2E3TnBMSzJPSmhfWDRFOVI2MmVJT2s4X0dVREE1eDM4aFBjd0hoUnowZlBjdGZmZUdzM0g2VGlmQTJ5bUJDTkdqN1ZLMEp2NFp4Xy1BRXNGcWRJblZOX2FLdm82UEk1REJrQXZubE5GNTdqN1ZmSjdvdkwwcHdMYVVhWFdnZkFYUmhDU3IySw?oc=5" target="_blank">Novo Nordisk Is Beating Eli Lilly in the Obesity Pill Market. Should Lilly Investors Be Worried?</a>  <font color="#6f6f6f">The Motley Fool</font>

Read Full StoryMore like this
Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)
Seeking Alphageneral

Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQNHZWZVUtZjV2Q0JFWU8wcUozWU1iTzVneDBadFBGa1NaQVBZTVl5UGIyVW15X1dKS3R6UFdIaVBlczlUanFBbkFvWTBSZ3ptdGNYTWdYUGxET3BLVGFvRUQ1WHp4cDZzZ2JfVkNGQXZqXzBHSXJfRUZIaUZKWFNXdmNXYTdiN1U4SEpRWGZBWWJ0bXhUX2RVMHZB?oc=5" target="_blank">Novo Nordisk's Wegovy Pill Escalates Eli Lilly Rivalry (NYSE:NVO)</a>  <font color="#6f6f6f">Seeking Alpha</font>

Read Full StoryMore like this
How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug (Published 2025)
The New York Timesgeneral

How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug (Published 2025)

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxQNE5IcktVWEFzclFsSGN5VU16QThCNEpUTHRFOGZ5UmJCWVUxMjZrNkxHVW8tajgzdDI2S29POFVQeFA1d0hXUWNZOXkxNmtpdEE1WXJrbjlTUldKaDRiNjNuR3FLcktvRWI2cm9jb0t1V2N3NTlvU3RWanVJbklJeE9SUm55YVJjcHNXZw?oc=5" target="_blank">How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug (Published 2025)</a>  <font color="#6f6f6f">The New York Times</font>

Read Full StoryMore like this
As India’s US$70 million obesity drug market bulges, so does price war
South China Morning Postmarkets

As India’s US$70 million obesity drug market bulges, so does price war

<a href="https://news.google.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?oc=5" target="_blank">As India’s US$70 million obesity drug market bulges, so does price war</a>  <font color="#6f6f6f">South China Morning Post</font>

Read Full StoryMore like this
"Lilly outpaces Novo as US" — Live Google News Trends & Headlines